Reviews Low Calcium Peritoneal Dialysis Solutions


No reviews yet.

Dianeal Low Calcium Drug Description
DIANEAL Low Calcium Peritoneal Dialysis Solution
Ambu-Flex III Container For Peritoneal Dialysis
For intraperitoneal administration only
DRUG DESCRIPTION
Dianeal Low Calcium peritoneal dialysis solutions are sterile, nonpyrogenic
solutions in Ambu-Flex III containers with flanged port for intraperitoneal
administration only. They contain no bacteriostatic or antimicrobial agents
or added buffers.







Composition, calculated osmolarity, pH and ionic concentrations are shown in
Table 1.
Potassium is omitted from peritoneal dialysis solutions because dialysis may
be performed to correct hyperkalemia. In situations in which there is a normal
serum potassium level or hypokalemia, the addition of potassium chloride (up
to a concentration of 4 mEq/L) may be indicated to prevent severe hypokalemia.
Addition of potassium chloride should be made after careful evaluation of
serum and total body potassium and only under the direction of a physician.
Frequent monitoring of serum electrolytes is indicated.
In some patients calcium carbonate is used as a phosphate binder. Because serum
calcium levels have been observed to be elevated in these patients (Slatopolsky
et al. 1986), the calcium concentration of Dianeal Low Calcium peritoneal
dialysis solutions has been reduced to 2.5 mEq/L. Serum calcium levels should
be monitored and if low, the amount of oral calcium carbonate phosphate binder
may be increased or peritoneal dialysis solutions containing higher calcium
concentrations may be used. If serum calcium levels rise, adjustments to the
dosage of the calcium carbonate phosphate binder and/or vitamin D analogs should
be considered by the physician.
Because average plasma magnesium levels in some chronic CAPD patients have
been observed to be elevated (Nolph et al. 1981), the magnesium concentration
of this formulation has been reduced to 0.5 mEq/L. Average plasma magnesium
levels have not been reported for chronic IPD and CCPD patients. Serum magnesium
levels should be monitored and if low, oral magnesium supplements, oral magnesium
containing phosphate binders, or peritoneal dialysis solutions containing higher
magnesium concentrations may be used.
Because average serum bicarbonate levels in some chronic CAPD patients (Nolph
et al. 1981), some chronic IPD patients (La Greca et al. 1980), and some chronic
CCPD patients (Diaz-Buxo et al. 1983), have been observed to be somewhat lower
than normal values, the bicarbonate precursor (lactate) concentration of Dianeal
Low Calcium peritoneal dialysis solutions has been raised to 40 mEq/L. Serum
bicarbonate levels should be monitored.
The osmolarities shown in Table 1 are calculated values. Calculated osmolarity
of Dianeal Low Calcium peritoneal dialysis solution with 1.5% dextrose
is 344 mOsmol/L, compared with measured values in normal human serum of 280
mOsmol/L.
The plastic container is fabricated from a specially formulated polyvinyl chloride
(PL 146 Plastic). The amount of water that can permeate from inside the
container into the overpouch is insufficient to affect the solution significantly.
Solutions in contact with the plastic container can leach out certain of its
chemical components in very small amounts within the expiration period, e.g.,
di-2-ethylhexyl phthalate (DEHP), at not more than 0.4 parts per million. This
level is well below the daily, tolerable intake level established by the FDA
for DEHP. Biological testing supports the safety of the plastic container materials.Last reviewed on RxList: 11/14/2008




Dianeal Low Calcium Drug Description
DIANEAL Low Calcium Peritoneal Dialysis Solution
Ambu-Flex III Container For Peritoneal Dialysis
For intraperitoneal administration only
DRUG DESCRIPTION
Dianeal Low Calcium peritoneal dialysis solutions are sterile, nonpyrogenic
solutions in Ambu-Flex III containers with flanged port for intraperitoneal
administration only. They contain no bacteriostatic or antimicrobial agents
or added buffers.







Composition, calculated osmolarity, pH and ionic concentrations are shown in
Table 1.
Potassium is omitted from peritoneal dialysis solutions because dialysis may
be performed to correct hyperkalemia. In situations in which there is a normal
serum potassium level or hypokalemia, the addition of potassium chloride (up
to a concentration of 4 mEq/L) may be indicated to prevent severe hypokalemia.
Addition of potassium chloride should be made after careful evaluation of
serum and total body potassium and only under the direction of a physician.
Frequent monitoring of serum electrolytes is indicated.
In some patients calcium carbonate is used as a phosphate binder. Because serum
calcium levels have been observed to be elevated in these patients (Slatopolsky
et al. 1986), the calcium concentration of Dianeal Low Calcium peritoneal
dialysis solutions has been reduced to 2.5 mEq/L. Serum calcium levels should
be monitored and if low, the amount of oral calcium carbonate phosphate binder
may be increased or peritoneal dialysis solutions containing higher calcium
concentrations may be used. If serum calcium levels rise, adjustments to the
dosage of the calcium carbonate phosphate binder and/or vitamin D analogs should
be considered by the physician.
Because average plasma magnesium levels in some chronic CAPD patients have
been observed to be elevated (Nolph et al. 1981), the magnesium concentration
of this formulation has been reduced to 0.5 mEq/L. Average plasma magnesium
levels have not been reported for chronic IPD and CCPD patients. Serum magnesium
levels should be monitored and if low, oral magnesium supplements, oral magnesium
containing phosphate binders, or peritoneal dialysis solutions containing higher
magnesium concentrations may be used.
Because average serum bicarbonate levels in some chronic CAPD patients (Nolph
et al. 1981), some chronic IPD patients (La Greca et al. 1980), and some chronic
CCPD patients (Diaz-Buxo et al. 1983), have been observed to be somewhat lower
than normal values, the bicarbonate precursor (lactate) concentration of Dianeal
Low Calcium peritoneal dialysis solutions has been raised to 40 mEq/L. Serum
bicarbonate levels should be monitored.
The osmolarities shown in Table 1 are calculated values. Calculated osmolarity
of Dianeal Low Calcium peritoneal dialysis solution with 1.5% dextrose
is 344 mOsmol/L, compared with measured values in normal human serum of 280
mOsmol/L.
The plastic container is fabricated from a specially formulated polyvinyl chloride
(PL 146 Plastic). The amount of water that can permeate from inside the
container into the overpouch is insufficient to affect the solution significantly.
Solutions in contact with the plastic container can leach out certain of its
chemical components in very small amounts within the expiration period, e.g.,
di-2-ethylhexyl phthalate (DEHP), at not more than 0.4 parts per million. This
level is well below the daily, tolerable intake level established by the FDA
for DEHP. Biological testing supports the safety of the plastic container materials.Last reviewed on RxList: 11/14/2008




Dianeal Low Calcium Drug Description
DIANEAL Low Calcium Peritoneal Dialysis Solution
Ambu-Flex III Container For Peritoneal Dialysis
For intraperitoneal administration only
DRUG DESCRIPTION
Dianeal Low Calcium peritoneal dialysis solutions are sterile, nonpyrogenic
solutions in Ambu-Flex III containers with flanged port for intraperitoneal
administration only. They contain no bacteriostatic or antimicrobial agents
or added buffers.







Composition, calculated osmolarity, pH and ionic concentrations are shown in
Table 1.
Potassium is omitted from peritoneal dialysis solutions because dialysis may
be performed to correct hyperkalemia. In situations in which there is a normal
serum potassium level or hypokalemia, the addition of potassium chloride (up
to a concentration of 4 mEq/L) may be indicated to prevent severe hypokalemia.
Addition of potassium chloride should be made after careful evaluation of
serum and total body potassium and only under the direction of a physician.
Frequent monitoring of serum electrolytes is indicated.
In some patients calcium carbonate is used as a phosphate binder. Because serum
calcium levels have been observed to be elevated in these patients (Slatopolsky
et al. 1986), the calcium concentration of Dianeal Low Calcium peritoneal
dialysis solutions has been reduced to 2.5 mEq/L. Serum calcium levels should
be monitored and if low, the amount of oral calcium carbonate phosphate binder
may be increased or peritoneal dialysis solutions containing higher calcium
concentrations may be used. If serum calcium levels rise, adjustments to the
dosage of the calcium carbonate phosphate binder and/or vitamin D analogs should
be considered by the physician.
Because average plasma magnesium levels in some chronic CAPD patients have
been observed to be elevated (Nolph et al. 1981), the magnesium concentration
of this formulation has been reduced to 0.5 mEq/L. Average plasma magnesium
levels have not been reported for chronic IPD and CCPD patients. Serum magnesium
levels should be monitored and if low, oral magnesium supplements, oral magnesium
containing phosphate binders, or peritoneal dialysis solutions containing higher
magnesium concentrations may be used.
Because average serum bicarbonate levels in some chronic CAPD patients (Nolph
et al. 1981), some chronic IPD patients (La Greca et al. 1980), and some chronic
CCPD patients (Diaz-Buxo et al. 1983), have been observed to be somewhat lower
than normal values, the bicarbonate precursor (lactate) concentration of Dianeal
Low Calcium peritoneal dialysis solutions has been raised to 40 mEq/L. Serum
bicarbonate levels should be monitored.
The osmolarities shown in Table 1 are calculated values. Calculated osmolarity
of Dianeal Low Calcium peritoneal dialysis solution with 1.5% dextrose
is 344 mOsmol/L, compared with measured values in normal human serum of 280
mOsmol/L.
The plastic container is fabricated from a specially formulated polyvinyl chloride
(PL 146 Plastic). The amount of water that can permeate from inside the
container into the overpouch is insufficient to affect the solution significantly.
Solutions in contact with the plastic container can leach out certain of its
chemical components in very small amounts within the expiration period, e.g.,
di-2-ethylhexyl phthalate (DEHP), at not more than 0.4 parts per million. This
level is well below the daily, tolerable intake level established by the FDA
for DEHP. Biological testing supports the safety of the plastic container materials.Last reviewed on RxList: 11/14/2008




Dianeal Low Calcium Drug Description
DIANEAL Low Calcium Peritoneal Dialysis Solution
Ambu-Flex III Container For Peritoneal Dialysis
For intraperitoneal administration only
DRUG DESCRIPTION
Dianeal Low Calcium peritoneal dialysis solutions are sterile, nonpyrogenic
solutions in Ambu-Flex III containers with flanged port for intraperitoneal
administration only. They contain no bacteriostatic or antimicrobial agents
or added buffers.







Composition, calculated osmolarity, pH and ionic concentrations are shown in
Table 1.
Potassium is omitted from peritoneal dialysis solutions because dialysis may
be performed to correct hyperkalemia. In situations in which there is a normal
serum potassium level or hypokalemia, the addition of potassium chloride (up
to a concentration of 4 mEq/L) may be indicated to prevent severe hypokalemia.
Addition of potassium chloride should be made after careful evaluation of
serum and total body potassium and only under the direction of a physician.
Frequent monitoring of serum electrolytes is indicated.
In some patients calcium carbonate is used as a phosphate binder. Because serum
calcium levels have been observed to be elevated in these patients (Slatopolsky
et al. 1986), the calcium concentration of Dianeal Low Calcium peritoneal
dialysis solutions has been reduced to 2.5 mEq/L. Serum calcium levels should
be monitored and if low, the amount of oral calcium carbonate phosphate binder
may be increased or peritoneal dialysis solutions containing higher calcium
concentrations may be used. If serum calcium levels rise, adjustments to the
dosage of the calcium carbonate phosphate binder and/or vitamin D analogs should
be considered by the physician.
Because average plasma magnesium levels in some chronic CAPD patients have
been observed to be elevated (Nolph et al. 1981), the magnesium concentration
of this formulation has been reduced to 0.5 mEq/L. Average plasma magnesium
levels have not been reported for chronic IPD and CCPD patients. Serum magnesium
levels should be monitored and if low, oral magnesium supplements, oral magnesium
containing phosphate binders, or peritoneal dialysis solutions containing higher
magnesium concentrations may be used.
Because average serum bicarbonate levels in some chronic CAPD patients (Nolph
et al. 1981), some chronic IPD patients (La Greca et al. 1980), and some chronic
CCPD patients (Diaz-Buxo et al. 1983), have been observed to be somewhat lower
than normal values, the bicarbonate precursor (lactate) concentration of Dianeal
Low Calcium peritoneal dialysis solutions has been raised to 40 mEq/L. Serum
bicarbonate levels should be monitored.
The osmolarities shown in Table 1 are calculated values. Calculated osmolarity
of Dianeal Low Calcium peritoneal dialysis solution with 1.5% dextrose
is 344 mOsmol/L, compared with measured values in normal human serum of 280
mOsmol/L.
The plastic container is fabricated from a specially formulated polyvinyl chloride
(PL 146 Plastic). The amount of water that can permeate from inside the
container into the overpouch is insufficient to affect the solution significantly.
Solutions in contact with the plastic container can leach out certain of its
chemical components in very small amounts within the expiration period, e.g.,
di-2-ethylhexyl phthalate (DEHP), at not more than 0.4 parts per million. This
level is well below the daily, tolerable intake level established by the FDA
for DEHP. Biological testing supports the safety of the plastic container materials.Last reviewed on RxList: 11/14/2008




Dianeal Low Calcium Drug Description
DIANEAL Low Calcium Peritoneal Dialysis Solution
Ambu-Flex III Container For Peritoneal Dialysis
For intraperitoneal administration only
DRUG DESCRIPTION
Dianeal Low Calcium peritoneal dialysis solutions are sterile, nonpyrogenic
solutions in Ambu-Flex III containers with flanged port for intraperitoneal
administration only. They contain no bacteriostatic or antimicrobial agents
or added buffers.







Composition, calculated osmolarity, pH and ionic concentrations are shown in
Table 1.
Potassium is omitted from peritoneal dialysis solutions because dialysis may
be performed to correct hyperkalemia. In situations in which there is a normal
serum potassium level or hypokalemia, the addition of potassium chloride (up
to a concentration of 4 mEq/L) may be indicated to prevent severe hypokalemia.
Addition of potassium chloride should be made after careful evaluation of
serum and total body potassium and only under the direction of a physician.
Frequent monitoring of serum electrolytes is indicated.
In some patients calcium carbonate is used as a phosphate binder. Because serum
calcium levels have been observed to be elevated in these patients (Slatopolsky
et al. 1986), the calcium concentration of Dianeal Low Calcium peritoneal
dialysis solutions has been reduced to 2.5 mEq/L. Serum calcium levels should
be monitored and if low, the amount of oral calcium carbonate phosphate binder
may be increased or peritoneal dialysis solutions containing higher calcium
concentrations may be used. If serum calcium levels rise, adjustments to the
dosage of the calcium carbonate phosphate binder and/or vitamin D analogs should
be considered by the physician.
Because average plasma magnesium levels in some chronic CAPD patients have
been observed to be elevated (Nolph et al. 1981), the magnesium concentration
of this formulation has been reduced to 0.5 mEq/L. Average plasma magnesium
levels have not been reported for chronic IPD and CCPD patients. Serum magnesium
levels should be monitored and if low, oral magnesium supplements, oral magnesium
containing phosphate binders, or peritoneal dialysis solutions containing higher
magnesium concentrations may be used.
Because average serum bicarbonate levels in some chronic CAPD patients (Nolph
et al. 1981), some chronic IPD patients (La Greca et al. 1980), and some chronic
CCPD patients (Diaz-Buxo et al. 1983), have been observed to be somewhat lower
than normal values, the bicarbonate precursor (lactate) concentration of Dianeal
Low Calcium peritoneal dialysis solutions has been raised to 40 mEq/L. Serum
bicarbonate levels should be monitored.
The osmolarities shown in Table 1 are calculated values. Calculated osmolarity
of Dianeal Low Calcium peritoneal dialysis solution with 1.5% dextrose
is 344 mOsmol/L, compared with measured values in normal human serum of 280
mOsmol/L.
The plastic container is fabricated from a specially formulated polyvinyl chloride
(PL 146 Plastic). The amount of water that can permeate from inside the
container into the overpouch is insufficient to affect the solution significantly.
Solutions in contact with the plastic container can leach out certain of its
chemical components in very small amounts within the expiration period, e.g.,
di-2-ethylhexyl phthalate (DEHP), at not more than 0.4 parts per million. This
level is well below the daily, tolerable intake level established by the FDA
for DEHP. Biological testing supports the safety of the plastic container materials.Last reviewed on RxList: 11/14/2008





Other reviews about Low Calcium Peritoneal Dialysis Solutions on wordpress

Multiple myeloma
  by hijadoo
INTRODUCTION — Multiple myeloma (MM) is a cancer of plasma cells in the bone marrow. Normally, plasma cells produce antibodies and play a key role in immune function. […]


Anesthesia Memos
  by mwhauser
AAA: ENDOVASCULAR The endovascular AAA repair is typically performed under high lumbar or low thoracic epidural anesthesia with MAC. LIDOCAINE is often a good choice as these patients […]


Fluids, Electrolytes, and Acid-Base Disorders
  by emergencymed
FLUIDS The body's response to fluid and electrolyte abnormalities is stratified. Our first concern, therefore, starts with oxygenation and ventilation, then circulation and, last, acid-base and electrolytes. When altered, […]


Nutrition
  by surgeryonline
Malnutrition In surgical practice malnutrition is common, being present before, or occurring after, operations in about 50per cent of patients, possibly more in some parts of the world. Preoperative malnutrition […]


Nephrology (part 1)
  by Markos Kashiouris
One of the most common causes of resistant HTN is sleep apnea - Do not forget.  HTN is associated with insulin resistance, sodium retention. When a CKD patient reaches […]


PBL: End Stage Renal Disease
  by terrichan
Theme: Love my cheesecake but hate my injections Keywords: 37 y/o woman visited nephrologist history of diabetes (since 15) & […]


Two hours and a half it is, said Mar
  by lreibhtgtqos
These same crossed plants were also to the offspring from the plants of the third generation crossed by the intercrossed plants of the corresponding generation, in height as […]


I challenge you to begin the test
  by sssejkfsxslp
But we dropped into this adventure rather unexpectedly. He thought of how much he had loved them, how much he would always love them. Of the four British […]


ejaculated Wabi for the twentieth ti
  by nwbuchdihytp
Instead of saying, as I often have, that very few species vary at the same time, I ought to have said, that very few species of a genus […]


William Darwin: If you c
  by hivajdnragytuje
Such affability and charm did he display that Frisco Kid, popping his head up through the scuttle to call them to supper, nearly choked in his effort to […]



Other reviews about Low Calcium Peritoneal Dialysis Solutions on web:

Learn about the prescription medication Dianeal Low Calcium (Low Calcium Peritoneal Dialysis Solutions), drug uses, dosage, side effects, drug interactions, warnings, reviews ... Dianeal Low Calcium (Low Calcium Peritoneal Dialysis Solutions ...


Dianeal With Dextrose Injection, Solution - DIANEAL Low Calcium peritoneal dialysis solutions are indicated for use in chronic renal ... Dianeal With Dextrose Injection, Solution drug information | MIMS ...


Home > Medical Drugs > Drugs beginning with D > Dianeal Low Calcium Peritoneal Dialysis SolutionUltraBag™ System For Continuous Ambulatory Peritoneal Dialysis (CAPD)For ... Dianeal Low Calcium Peritoneal Dialysis SolutionUltraBag™ System ...


Accurate, FDA approved Dianeal Low Calcium Peritoneal Dialysis Solution information for healthcare professionals and patients - brought to you by Drugs.com. Dianeal Low Calcium Peritoneal Dialysis Solution Official FDA ...


FOR INFORMA T ION ONL Y Dianeal ® Low Calcium 5.2 Peritoneal 1500 2000 5B9795 0941-0433-51 Dialysis 4.25 538 448 18.35.08 483 (4.01322.50.59540200020005B9796 0941-0433-52 ... Dianeal®Low Calcium Peritoneal Dialysis Solution


A peritoneal dialysis solution ... calcium; and . 0.0 to about 4.0 (meq/L) magnesium. In an embodiment, the peritoneal dialysis solution has ... of peritoneal dialysis solutions with low ... Low sodium peritoneal dialysis solution - Patent 5589197


Dianeal Low Calcium Peritoneal Dialysis Solution Dung dòch thaåm phaân phuùc maïc - Dextrose. Dianeal Low Calcium Peritoneal Dialysis Solution Dung dòch thaåm ...


STERISOL ® PERITONEAL DIALYSIS SOLUTION WITH DEXTROSE 1,5% m/v STERISOL ® LOW SODIUM PERIDIASOL WITH 2% m/v DEXTROSE ... Calcium chloride .2H 2 0-260 mg: 260 mg: Calcium chloride .6H 2 0: 363 ... STERISOL® PERITONEAL DIALYSIS SOLUTION WITH DEXTROSE 1,5% m/v ...


Calcium Chloride ... and if low, oral magnesium supplements, oral magnesium containing phosphate binders, or peritoneal dialysis solutions ... DIANEAL peritoneal dialysis solutions ... Dianeal PD-2 (Peritoneal Dialysis Solution) Drug Information: Uses ...


Find out all about low calcium peritoneal dialysis solutions side effects, including the most common uses, side effects, interactions and risk factors from leading medical experts. Low Calcium Peritoneal Dialysis Solutions Side Effects - a ...





Featured Reviews

Reviews Renese

Renese Drug Description RENESE® (polythiazide) Tablets for Oral Administration DRUG DESCRIPTION Renese® is designated generically as polythiazide, and chemically as 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-2-methyl-3...
Read More  |  Review This
Reviews Andreea Raicu

I've met Andreea Raicu (from Prima TV) last week, being recommed to her by another celebrity that it's between my clients. I was very impress. She is very connected, very smart and she knows a lot of things regarding internet and emarketing...
Read More  |  Review This
Reviews Xyrem

Xyrem Drug Description Xyrem® (sodium oxybate) Oral Solution WARNING: Central nervous system depressant with abuse potential. Should not be used with alcohol or other CNS depressants. Sodium oxybate is GHB, a known drug of abuse....
Read More  |  Review This
Reviews Extavia

Extavia Drug Description Extavia (interferon beta-1b) Kit for Subcutaneous Use DRUG DESCRIPTION EXTAVIA® (interferon beta-1b) is a purified, sterile, lyophilized protein product produced by recombinant DNA techniques. Interferon...
Read More  |  Review This
Reviews Valproate Sodium Injection

Depacon Drug Description DEPACON® (valproate sodium) Injection BOX WARNING HEPATOTOXICITY HEPATIC FAILURE RESULTING IN FATALITIES HAS OCCURRED IN PATIENTS RECEIVING VALPROIC ACID AND ITS DERIVATIVES. EXPERIENCE HAS INDICATED THAT...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....